The Neuroprotective Role of Exercise in Alzheimer’s Disease: An Integrative Review of Animal and Human Studies
Open Access
- 8 June 2026
- journal article
- review article
- Published by MDPI AG in Neurology International
- Vol. 18 (6) , 113
Abstract
Alzheimer’s disease (AD), the leading cause of dementia, is characterized by progressive cognitive decline along with hallmark brain pathologies including amyloid-beta accumulation, hyperphosphorylated tau, neuroinflammation and neuronal mitochondrial dysfunction. As current pharmaceutical treatments only provide modest symptomatic improvement, there is an urgent need for effective non-pharmaceutical treatment options for the prevention or slowing down of this disease. This review synthesizes results from randomized controlled trials, observational studies, and animal model research on the ability of exercise to influence cognitive functions, brain structural changes, inflammatory processes, and neuroplasticity-related pathways. Exercise has demonstrated the capacity to enhance neurotrophic signaling, improve the regulation of mitochondria, improve cerebrovascular function and reduce pro-inflammatory cytokine levels in preclinical and mild cognitive impairment (MCI) subjects. Additionally, aerobic and resistance training has been shown to enhance physical performance and functional capacity. Furthermore, mind–body, dual-task and multimodal types of interventions may also provide additional cognitive and psychological benefits. Although the overall cognitive effect of exercise in individuals with established AD is generally small, it has been demonstrated that exercise can contribute to maintaining brain health through multiple interconnected metabolic, vascular and molecular pathways, thereby preserving cognitive reserve and slowing disease progression, particularly when initiated during early to midlife prior to the onset of AD symptoms. Therefore, future research will require establishing stage-specific exercise recommendations based on modality type, intensity and duration to achieve optimal clinical outcomes.Keywords
This publication has 175 references indexed in Scilit:
- Physical activity changes during midlife link to brain integrity and amyloid burdenAlzheimer's & Dementia, 2025
- Effects of exercise on cognition and Alzheimer's biomarkers in a randomized controlled trial of adults with mild cognitive impairment: The EXERT studyAlzheimer's & Dementia, 2025
- Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer DiseaseJAMA Neurology, 2025
- 2024 Alzheimer's disease facts and figuresAlzheimer's & Dementia, 2024
- Japan‐Multimodal Intervention Trial for the Prevention of Dementia: A randomized controlled trialAlzheimer's & Dementia, 2024
- Effects of Exercise Alone or Combined With Cognitive Training and Vitamin D Supplementation to Improve Cognition in Adults With Mild Cognitive ImpairmentJAMA Network Open, 2023
- Effects of Mindfulness Training and Exercise on Cognitive Function in Older AdultsJAMA, 2022
- Effect of Exercise Training or Complex Mental and Social Activities on Cognitive Function in Adults With Chronic StrokeJAMA Network Open, 2022
- Effects of the Finnish Alzheimer Disease Exercise Trial (FINALEX)JAMA Internal Medicine, 2013
- Resistance Training and Executive FunctionsArchives of internal medicine (1960), 2010